Darya Rose

Darya Rose is a seasoned professional in market access strategy, currently serving as the Director of Global Value & Access Strategy at Gilead Sciences, a position she has held since April 2022. Based in Redwood City, California, she has accumulated over 15 years of experience in the life sciences industry, focusing on market access and managed markets marketing.12

Professional Experience

• Gilead Sciences

  • Director, Global Value & Access Strategy (April 2022 - Present)
  • Associate Director, Managed Markets Marketing (March 2021 - April 2022)
  • Senior Manager, Managed Markets Marketing (September 2019 - February 2021)

• Analysis Group

  • Manager (January 2016 - September 2019)
  • Associate (July 2013 - December 2015)

• Genentech

  • Market Planning Intern, Pulmozyme (November 2012 - April 2013)

• Tobira Therapeutics, Inc.

  • Corporate Development Intern (June 2012 - August 2012)

• Cornerstone Research

  • Research Associate (June 2007 - June 2011)

Education

• MBA in Healthcare Management, University of California, Berkeley - Walter A. Haas School of Business (2011-2013)
• Bachelor of Science in International Political Economy, Georgetown University (2003-2007), graduated summa cum laude
• Undergraduate Exchange Program in Economics and Politics, Sciences Po (2006)

Skills and Languages

Darya is fluent in both French and Russian, enhancing her ability to navigate global markets and engage with diverse stakeholders.1

Her extensive background and leadership in market access strategy make her a key player at Gilead Sciences, contributing to the company's initiatives in global health and patient access to therapies.